StockData

Yarrow Bioscience, Inc. (YARW) stock

YARWNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 11/30102% above fair value
$14.35+0.14 (+0.99%)

Close on Nov 18, 2026Market cap $38.31MP/E –Yield –

Yarrow Bioscience operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Yarrow Bioscience's operating cash flow for the twelve months ending Jun 30, 2025 was -$39.77M. For fiscal 2025 it was -$33.12M. The highest annual figure on record is -$2.27M in fiscal 2016.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$33.12M–
FY2024Dec 31, 2024-$33.97M–
FY2023Dec 31, 2023-$25.34M–
FY2022Dec 31, 2022-$29.20M–
FY2021Dec 31, 2021-$56.37M–
FY2020Dec 31, 2020-$137.08M–
FY2019Dec 31, 2019-$73.39M–
FY2018Dec 31, 2018-$68.66M–
FY2017Dec 31, 2017-$28.22M–
FY2016Dec 31, 2016-$2.27M–
FY2015Dec 31, 2015-$4.18M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$1.99M–
Q1 FY2026Mar 31, 2026-$4.08M–
Q2 FY2025Jun 30, 2025-$10.80M–
Q1 FY2025Mar 31, 2025-$11.46M–
Q4 FY2024Dec 31, 2024-$9.00M–
Q3 FY2024Sep 30, 2024-$8.51M–
Q2 FY2024Jun 30, 2024-$8.48M–
Q1 FY2024Mar 31, 2024-$7.98M–
Q4 FY2023Dec 31, 2023-$5.14M–
Q3 FY2023Sep 30, 2023-$5.15M–
Q2 FY2023Jun 30, 2023-$9.57M–
Q1 FY2023Mar 31, 2023-$5.48M–
Q4 FY2022Dec 31, 2022-$4.81M–
Q3 FY2022Sep 30, 2022-$7.13M–
Q2 FY2022Jun 30, 2022-$8.23M–
Q1 FY2022Mar 31, 2022-$9.04M–
Q4 FY2021Dec 31, 2021-$10.02M–
Q3 FY2021Sep 30, 2021-$17.54M–
Q2 FY2021Jun 30, 2021-$16.26M–
Q1 FY2021Mar 31, 2021-$12.55M–
Q4 FY2020Dec 31, 2020-$25.38M–
Q3 FY2020Sep 30, 2020-$23.64M–
Q2 FY2020Jun 30, 2020-$35.86M–
Q1 FY2020Mar 31, 2020-$52.21M–
Q4 FY2019Dec 31, 2019-$22.25M–
Q3 FY2019Sep 30, 2019-$21.79M–
Q2 FY2019Jun 30, 2019-$12.72M–
Q1 FY2019Mar 31, 2019-$16.64M–
Q4 FY2018Dec 31, 2018-$32.55M–
Q3 FY2018Sep 30, 2018-$12.17M–
Q2 FY2018Jun 30, 2018-$12.74M-34537.8%
Q1 FY2018Mar 31, 2018-$11.20M–
Q4 FY2017Dec 31, 2017-$10.16M–
Q3 FY2017Sep 30, 2017-$12.52M–
Q2 FY2017Jun 30, 2017$37.00K–
Q1 FY2017Mar 31, 2017-$5.58M–

More Yarrow Bioscience figures

See a number that looks wrong?